Cellular and Immunotherapy Research in Pediatric Oncology Endowed Position within Bone Marrow Transplant Penn State Children’s Hospital Pennsylvania State University College of Medicine

Penn State Children’s Hospital is recruiting outstanding a physician scientist for the newly endowed Cellular and Immunotherapy Research Program in Pediatric Oncology within the Division of Pediatric Hematology/Oncology in Bone Marrow Transplant. This Program is supported by a substantial endowment from the Four Diamonds Fund of the PSU College of Medicine, part of a >$100 M endowment supporting the Four Diamonds Pediatric Cancer Research Center. This Program is part of an interdepartmental genetics initiative by the institution. The mission of the Pediatric Oncology Cellular and Immunotherapy Research Program is to study immune regulation and develop new cellular and immune mediated therapies to better understand and design novel therapies for pediatric cancers. A wide range of model systems and experimental approaches are of interest and strong collaborations between basic and clinical research and clinical research trials are encouraged. This is a tenure track position and rank is at the Associate to Full Professor level commensurate with the applicant’s experience and accomplishments. Successful applicants will have an M.D./Ph.D., or M.D. degree with an established track record in cancer research and demonstrated ability to obtain extramural funding.

The Division of Pediatric Hematology/Oncology has 15 full-time Pediatric Hematologists/Oncologists and 12 Ph.D. faculty. Over 100 new oncology patients are seen annually, and there are programs in pediatric stem cell transplantation, experimental therapeutics, neuro-oncology, AYA oncology, and survivorship. The division has an accredited Pediatric Heme/Onc fellowship program and is an active member of COG, POETIC, and the lead organization for the Beat Childhood Cancer Research Consortium. The Four Diamonds Pediatric Cancer Research Program consists of NIH-funded basic and translational research in childhood malignancies including leukemia, solid tumors, and brain tumors. Research is supported by the Penn State Cancer Institute, the Penn State Institute for Personalized Medicine, an NIH-funded CTSI, and Pediatric Clinical Trials Office. Basic core, translational, and clinical facilities provide an excellent environment for research.

Please submit a current CV and letter of interest to: Giselle Saulnier Sholler, M.D. ([email protected] ), Chief, Division of Pediatric Hematology/Oncology, Penn State Children’s Hospital, the Pennsylvania State University College of Medicine, Box 850, MC H085, Hershey, Pennsylvania 17033. Applications are accepted until position filled.

Penn State Health is fundamentally committed to the diversity of our faculty and staff. We believe diversity is unapologetically expressing itself through every person’s perspectives and lived experiences. We are an equal opportunity and affirmative action employer. All qualified applicants will receive consideration for employment without regard to age, color, disability, gender identity or expression, marital status, national or ethnic origin, political affiliation, race, religion, sex (including pregnancy), sexual orientation, veteran status, and family medical or genetic information. If you are unable to use our online application process due to an impairment or disability, please call 717-531-8440 between the hours of 8:30 AM and 4:30 PM, Eastern Standard Time, Monday – Friday, email [email protected] or download our Accommodation Instructions for Job Applicants PDF for more detailed steps for assistance.

Please submit a current CV and letter of interest to: Giselle Saulnier Sholler, M.D. ([email protected] ), Chief, Division of Pediatric Hematology/Oncology, Penn State Children’s Hospital, the Pennsylvania State University College of Medicine, Box 850, MC H085, Hershey, Pennsylvania 17033. Applications are accepted until position filled.